Exosomal miRNAs as Potential Diagnostic Biomarkers in Alzheimer’s Disease

Alzheimer’s disease (AD), a neurodegenerative disease, is linked to a variety of internal and external factors present from the early stages of the disease. There are several risk factors related to the pathogenesis of AD, among these exosomes and microRNAs (miRNAs) are of particular importance. Exo...

Full description

Bibliographic Details
Main Authors: Ida Manna, Selene De Benedittis, Andrea Quattrone, Domenico Maisano, Enrico Iaccino, Aldo Quattrone
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/13/9/243
_version_ 1797553847013474304
author Ida Manna
Selene De Benedittis
Andrea Quattrone
Domenico Maisano
Enrico Iaccino
Aldo Quattrone
author_facet Ida Manna
Selene De Benedittis
Andrea Quattrone
Domenico Maisano
Enrico Iaccino
Aldo Quattrone
author_sort Ida Manna
collection DOAJ
description Alzheimer’s disease (AD), a neurodegenerative disease, is linked to a variety of internal and external factors present from the early stages of the disease. There are several risk factors related to the pathogenesis of AD, among these exosomes and microRNAs (miRNAs) are of particular importance. Exosomes are nanocarriers released from many different cell types, including neuronal cells. Through the transfer of bioactive molecules, they play an important role both in the maintenance of physiological and in pathological conditions. Exosomes could be carriers of potential biomarkers useful for the assessment of disease progression and for therapeutic applications. miRNAs are small noncoding endogenous RNA sequences active in the regulation of protein expression, and alteration of miRNA expression can result in a dysregulation of key genes and pathways that contribute to disease development. Indeed, the involvement of exosomal miRNAs has been highlighted in various neurodegenerative diseases, and this opens the possibility that dysregulated exosomal miRNA profiles may influence AD disease. The advances in exosome-related biomarker detection in AD are summarized. Finally, in this review, we highlight the use of exosomal miRNAs as essential biomarkers in preclinical and clinical studies in Alzheimer’s disease, also taking a look at their potential clinical value.
first_indexed 2024-03-10T16:22:27Z
format Article
id doaj.art-57c23b47cdd14aee966338fa9613bf06
institution Directory Open Access Journal
issn 1424-8247
language English
last_indexed 2024-03-10T16:22:27Z
publishDate 2020-09-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj.art-57c23b47cdd14aee966338fa9613bf062023-11-20T13:33:42ZengMDPI AGPharmaceuticals1424-82472020-09-0113924310.3390/ph13090243Exosomal miRNAs as Potential Diagnostic Biomarkers in Alzheimer’s DiseaseIda Manna0Selene De Benedittis1Andrea Quattrone2Domenico Maisano3Enrico Iaccino4Aldo Quattrone5Institute of Molecular Bioimaging and Physiology (IBFM), National Research Council (CNR), Section of Germaneto, 88100 Catanzaro, ItalyDepartment of Medical and Surgical Sciences, University “Magna Graecia,” Germaneto, 88100 Catanzaro, ItalyInstitute of Neurology, Department of Medical and Surgical Sciences, University “Magna Graecia,” Germaneto, 88100 Catanzaro, ItalyDepartment of Experimental and Clinical Medicine, University “Magna Graecia” of Catanzaro, 88100 Catanzaro, ItalyDepartment of Experimental and Clinical Medicine, University “Magna Graecia” of Catanzaro, 88100 Catanzaro, ItalyInstitute of Molecular Bioimaging and Physiology (IBFM), National Research Council (CNR), Section of Germaneto, 88100 Catanzaro, ItalyAlzheimer’s disease (AD), a neurodegenerative disease, is linked to a variety of internal and external factors present from the early stages of the disease. There are several risk factors related to the pathogenesis of AD, among these exosomes and microRNAs (miRNAs) are of particular importance. Exosomes are nanocarriers released from many different cell types, including neuronal cells. Through the transfer of bioactive molecules, they play an important role both in the maintenance of physiological and in pathological conditions. Exosomes could be carriers of potential biomarkers useful for the assessment of disease progression and for therapeutic applications. miRNAs are small noncoding endogenous RNA sequences active in the regulation of protein expression, and alteration of miRNA expression can result in a dysregulation of key genes and pathways that contribute to disease development. Indeed, the involvement of exosomal miRNAs has been highlighted in various neurodegenerative diseases, and this opens the possibility that dysregulated exosomal miRNA profiles may influence AD disease. The advances in exosome-related biomarker detection in AD are summarized. Finally, in this review, we highlight the use of exosomal miRNAs as essential biomarkers in preclinical and clinical studies in Alzheimer’s disease, also taking a look at their potential clinical value.https://www.mdpi.com/1424-8247/13/9/243neurodegenerationAlzheimer’s diseasebiomarkersmiRNAsexosomesexosomal miRNAs
spellingShingle Ida Manna
Selene De Benedittis
Andrea Quattrone
Domenico Maisano
Enrico Iaccino
Aldo Quattrone
Exosomal miRNAs as Potential Diagnostic Biomarkers in Alzheimer’s Disease
Pharmaceuticals
neurodegeneration
Alzheimer’s disease
biomarkers
miRNAs
exosomes
exosomal miRNAs
title Exosomal miRNAs as Potential Diagnostic Biomarkers in Alzheimer’s Disease
title_full Exosomal miRNAs as Potential Diagnostic Biomarkers in Alzheimer’s Disease
title_fullStr Exosomal miRNAs as Potential Diagnostic Biomarkers in Alzheimer’s Disease
title_full_unstemmed Exosomal miRNAs as Potential Diagnostic Biomarkers in Alzheimer’s Disease
title_short Exosomal miRNAs as Potential Diagnostic Biomarkers in Alzheimer’s Disease
title_sort exosomal mirnas as potential diagnostic biomarkers in alzheimer s disease
topic neurodegeneration
Alzheimer’s disease
biomarkers
miRNAs
exosomes
exosomal miRNAs
url https://www.mdpi.com/1424-8247/13/9/243
work_keys_str_mv AT idamanna exosomalmirnasaspotentialdiagnosticbiomarkersinalzheimersdisease
AT selenedebenedittis exosomalmirnasaspotentialdiagnosticbiomarkersinalzheimersdisease
AT andreaquattrone exosomalmirnasaspotentialdiagnosticbiomarkersinalzheimersdisease
AT domenicomaisano exosomalmirnasaspotentialdiagnosticbiomarkersinalzheimersdisease
AT enricoiaccino exosomalmirnasaspotentialdiagnosticbiomarkersinalzheimersdisease
AT aldoquattrone exosomalmirnasaspotentialdiagnosticbiomarkersinalzheimersdisease